R Theodore Schroeder

Affiliations

  • Director at Cidara Therapeutics Inc. (CDTX), 2024-07-19
  • Director at Nabriva Therapeutics Plc (NBRV), 2023-02-01
  • Director at Otonomy Inc. (OTIC), 2022-06-23
  • Director at Collegium Pharmaceutical Inc (COLL), 2020-05-22
  • Director at Hyperion Therapeutics Inc (HPTX), 2015-05-08
  • President, Ceo at Cadence Pharmaceuticals Inc (CADX), 2014-03-21
  • Director at Trius Therapeutics Inc (TSRX), 2013-09-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NBRV $0.57 100,000 Officer, Director 325,879 2021-12-28 Filing
NBRV $1.13 50,000 Officer, Director 226,875 2021-09-14 Filing
NBRV $1.79 50,000 Officer, Director 117,489 2019-08-27 Filing
CADX $7.48 16,000 Officer, Director 307,500 2011-05-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CADX $8.35 9,297 Officer, Director 311,000 2010-10-01 Filing
CADX $8.35 40,703 Officer, Director 320,297 2010-09-30 Filing
CADX $6.95 8,979 Officer, Director 361,000 2010-07-01 Filing
CADX $7.00 41,021 Officer, Director 369,979 2010-06-30 Filing
CADX $9.03 21,997 Officer, Director 411,000 2010-04-01 Filing